MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patients

Richard Harrop, William H. Shingler, Mike McDonald, Peter Treasure, Robert J. Amato, Robert E. Hawkins, Howard L. Kaufman, Jackie De Belin, Michelle Kelleher, Madusha Goonewardena, Stuart Naylor

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patients'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology

    Biochemistry, Genetics and Molecular Biology